X4 Pharmaceuticals

XFOR

Capitalización de mercado USD 319 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Bain Capital Life Sciences Investors Boston, Massachusetts	USD 11.3 M	–	–	–
2	2 NEA Management Company Timonium, Maryland	USD 10 M	–	–	–
3	3 BlackRock New York	USD 7.5 M	+USD 372 k	+17,824	+5%
4	4 Vanguard Group Malvern, Pennsylvania	USD 5.65 M	+USD 105 k	+5,023	+2%
5	5 OrbiMed New York	USD 4.77 M	–	–	–
6	KCM 6 Kingdon Capital Management New York	USD 3.1 M	+USD 10.4 k	+500	+0.3%
7	7 Adage Capital Partners Boston, Massachusetts	USD 2.86 M	–	–	–
8	8 Perceptive Advisors New York	USD 2.37 M	–	–	–
9	9 Geode Capital Management Boston, Massachusetts	USD 2.31 M	-USD 47.3 k	-2,268	-2%
10	10 Axa Paris, France	USD 2.06 M	+USD 605	+29	+0%
11	11 State Street Boston, Massachusetts	USD 1.98 M	+USD 132 k	+6,304	+7%
12	12 Ensign Peak Advisors Salt Lake City, Utah	USD 1.7 M	–	–	–
13	13 Schonfeld Strategic Advisors New York	USD 1.29 M	+USD 453 k	+21,704	+51%
14	14 Pale Fire Capital SE Prague, Czech Republic	USD 1.07 M	+USD 992 k	+47,525	+805%
15	15 UBS O'Connor Chicago, Illinois	USD 1.04 M	+USD 270 k	+12,961	+34%
16	16 Northern Trust Chicago, Illinois	USD 883 k	+USD 183 k	+8,787	+25%
17	17 Sio Capital Management New York	USD 872 k	-USD 832 k	-39,877	-48%
18	18 Parkman Healthcare Partners Stamford, Connecticut	USD 548 k	+USD 8.43 k	+404	+2%
19	19 AQR Capital Management Greenwich, Connecticut	USD 479 k	+USD 203 k	+9,722	+69%
20	20 Point72 Asset Management Stamford, Connecticut	USD 418 k	+USD 57 k	+2,732	+15%
21	21 GSA Capital Partners London, United Kingdom	USD 340 k	+USD 353 k	+16,923	Nuevas
22	22 Nuveen Charlotte, North Carolina	USD 334 k	–	–	–
23	23 Morgan Stanley New York	USD 328 k	+USD 182 k	+8,710	+114%
24	24 Charles Schwab San Francisco, California	USD 293 k	–	–	–
25	25 Millennium Management New York	USD 243 k	+USD 13.8 k	+660	+6%

X4 Pharmaceuticals XFOR Capitalización de mercado USD 319 M

X4 Pharmaceuticals

XFOR

Capitalización de mercado USD 319 M